Critical study of Gilead’s Covid-19 drug shows patients are responding to treatment, NIH says

A government-run study of Gilead’s remdesivir, perhaps the most closely watched experimental drug to treat the novel coronavirus, showed that the medicine is effective against Covid-19, the disease caused by the virus.